Latest filing published 14 Sept 2026 for Telix Pharmaceuticals Ltd, €17k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -16.7%Entry US$12.83 · Close 16 Oct 2026 US$10.69
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Darren Charlton Smith: trading record in brief
This profile gathers the share dealings of Darren Charlton Smith in Telix Pharmaceuticals Ltd. The record holds 2 filings, for trades running from 29 March 2026 to 7 September 2026.
Purchases make up the whole of the open-market record (1 purchase, €17k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise.
The record was last updated on 14 September 2026 with an open-market purchase (€17k) in Telix Pharmaceuticals Ltd. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Darren Charlton Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,071 shares@ US$9.6560.0005% mcap100.0% of flowOrdinary SharesSEC:0001628280-26-061944:0Canonical exit: 6 Dec 2026 (T+90)
- 1,111 shares0Ordinary SharesSEC:0001628280-26-022909:0
2 of 2 declarations